To access this element change to forms mode OFF
Grant Award View - GA18493
Targeting HCK in Pancreatic Ductal Adenocarcinoma to Restrict Tumour...
GA ID:
GA18493
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
16-Jul-2018
Publish Date:
16-Aug-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$327,192.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Early Career Fellowships
Grant Activity:
Targeting HCK in Pancreatic Ductal Adenocarcinoma to Restrict Tumour Growth and Metastasis
Purpose:
This project will define the therapeutic benefit of targeting a protein known as Haematopoietic Cell Kinase (HCK) in pancreatic ductal adenocarcinoma. Increased HCK activity promotes tumour growth by facilitating the polarisation of macrophages towards an alternatively activated “tumourigenic” endotype, which are a major component of pancreatic tumours. We hypothesise that the therapeutic targeting of HCK will reduce pancreatic tumour growth by impairing alternative macrophage polarisation.
GO ID:
GO Title:
NHMRC Early Career Fellowship for Funding 2019
Internal Reference ID:
GNT1166447
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
La Trobe University
Recipient ABN:
64 804 735 113
Grant Recipient Location
Suburb:
Bundoora
Town/City:
Bundoora
Postcode:
3083
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA